Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

Bristol-Myers Squibb · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
nivolumab
extensive-stage small cell lung cancer, bms-986012, carboplatin, etoposide, fucosyl, nivolumab, targeted sclc therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 865729
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.